These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

839 related items for PubMed ID: 18263803

  • 1. Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation.
    Glanville AR, Aboyoun CL, Havryk A, Plit M, Rainer S, Malouf MA.
    Am J Respir Crit Care Med; 2008 May 01; 177(9):1033-40. PubMed ID: 18263803
    [Abstract] [Full Text] [Related]

  • 2. Long-term survival after lung transplantation depends on development and severity of bronchiolitis obliterans syndrome.
    Burton CM, Carlsen J, Mortensen J, Andersen CB, Milman N, Iversen M.
    J Heart Lung Transplant; 2007 Jul 01; 26(7):681-6. PubMed ID: 17613397
    [Abstract] [Full Text] [Related]

  • 3. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
    Heng D, Sharples LD, McNeil K, Stewart S, Wreghitt T, Wallwork J.
    J Heart Lung Transplant; 1998 Dec 01; 17(12):1255-63. PubMed ID: 9883768
    [Abstract] [Full Text] [Related]

  • 4. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome.
    Daud SA, Yusen RD, Meyers BF, Chakinala MM, Walter MJ, Aloush AA, Patterson GA, Trulock EP, Hachem RR.
    Am J Respir Crit Care Med; 2007 Mar 01; 175(5):507-13. PubMed ID: 17158279
    [Abstract] [Full Text] [Related]

  • 5. Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.
    Valentine VG, Gupta MR, Walker JE, Seoane L, Bonvillain RW, Lombard GA, Weill D, Dhillon GS.
    J Heart Lung Transplant; 2009 Feb 01; 28(2):163-9. PubMed ID: 19201342
    [Abstract] [Full Text] [Related]

  • 6. Acute cellular rejection is a risk factor for bronchiolitis obliterans syndrome independent of post-transplant baseline FEV1.
    Burton CM, Iversen M, Carlsen J, Mortensen J, Andersen CB, Steinbrüchel D, Scheike T.
    J Heart Lung Transplant; 2009 Sep 01; 28(9):888-93. PubMed ID: 19716040
    [Abstract] [Full Text] [Related]

  • 7. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
    Burton CM, Iversen M, Mortensen J, Carlsen J, Andersen CB, Milman N, Scheike T.
    J Heart Lung Transplant; 2007 Nov 01; 26(11):1127-34. PubMed ID: 18022078
    [Abstract] [Full Text] [Related]

  • 8. "Refractoriness" of airflow obstruction associated with isolated lymphocytic bronchiolitis/bronchitis in pulmonary allografts.
    Ross DJ, Marchevsky A, Kramer M, Kass RM.
    J Heart Lung Transplant; 1997 Aug 01; 16(8):832-8. PubMed ID: 9286775
    [Abstract] [Full Text] [Related]

  • 9. Risk factors for the development of obliterative bronchiolitis after lung transplantation.
    Girgis RE, Tu I, Berry GJ, Reichenspurner H, Valentine VG, Conte JV, Ting A, Johnstone I, Miller J, Robbins RC, Reitz BA, Theodore J.
    J Heart Lung Transplant; 1996 Dec 01; 15(12):1200-8. PubMed ID: 8981205
    [Abstract] [Full Text] [Related]

  • 10. Is lymphocytic bronchiolitis a marker of acute rejection? An analysis of 2,697 transbronchial biopsies after lung transplantation.
    Burton CM, Iversen M, Scheike T, Carlsen J, Andersen CB.
    J Heart Lung Transplant; 2008 Oct 01; 27(10):1128-34. PubMed ID: 18926405
    [Abstract] [Full Text] [Related]

  • 11. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation.
    Ailawadi G, Smith PW, Oka T, Wang H, Kozower BD, Daniel TM, Kron IL, Jones DR.
    J Thorac Cardiovasc Surg; 2008 Mar 01; 135(3):594-602. PubMed ID: 18329476
    [Abstract] [Full Text] [Related]

  • 12. A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients.
    Kumar D, Husain S, Chen MH, Moussa G, Himsworth D, Manuel O, Studer S, Pakstis D, McCurry K, Doucette K, Pilewski J, Janeczko R, Humar A.
    Transplantation; 2010 Apr 27; 89(8):1028-33. PubMed ID: 20075787
    [Abstract] [Full Text] [Related]

  • 13. Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome?
    Moffatt-Bruce SD, Karamichalis J, Robbins RC, Whyte RI, Theodore J, Reitz BA.
    Ann Thorac Surg; 2006 Jan 27; 81(1):286-91; discussion 291. PubMed ID: 16368382
    [Abstract] [Full Text] [Related]

  • 14. Airway vascular changes after lung transplant: potential contribution to the pathophysiology of bronchiolitis obliterans syndrome.
    Langenbach SY, Zheng L, McWilliams T, Levvey B, Orsida B, Bailey M, Williams TJ, Snell GI.
    J Heart Lung Transplant; 2005 Oct 27; 24(10):1550-6. PubMed ID: 16210129
    [Abstract] [Full Text] [Related]

  • 15. Revisiting the pathologic finding of diffuse alveolar damage after lung transplantation.
    Sato M, Hwang DM, Ohmori-Matsuda K, Chaparro C, Waddell TK, Singer LG, Hutcheon MA, Keshavjee S.
    J Heart Lung Transplant; 2012 Apr 27; 31(4):354-63. PubMed ID: 22330935
    [Abstract] [Full Text] [Related]

  • 16. Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation.
    Treede H, Glanville AR, Klepetko W, Aboyoun C, Vettorazzi E, Lama R, Bravo C, Knoop C, Aubert JD, Reichenspurner H, European and Australian Investigators in Lung Transplantation.
    J Heart Lung Transplant; 2012 Aug 27; 31(8):797-804. PubMed ID: 22554673
    [Abstract] [Full Text] [Related]

  • 17. Effect of adherence to home spirometry on bronchiolitis obliterans and graft survival after lung transplantation.
    Kugler C, Fuehner T, Dierich M, DeWall C, Haverich A, Simon A, Welte T, Gottlieb J.
    Transplantation; 2009 Jul 15; 88(1):129-34. PubMed ID: 19584692
    [Abstract] [Full Text] [Related]

  • 18. Bronchiolitis obliterans syndrome development in lung transplantation patients.
    Parada MT, Alba A, Sepúlveda C.
    Transplant Proc; 2010 Jul 15; 42(1):331-2. PubMed ID: 20172344
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients.
    Neurohr C, Huppmann P, Samweber B, Leuschner S, Zimmermann G, Leuchte H, Baumgartner R, Hatz R, Frey L, Ueberfuhr P, Bittmann I, Behr J, Munich Lung Transplant Group.
    J Heart Lung Transplant; 2009 May 15; 28(5):468-74. PubMed ID: 19416775
    [Abstract] [Full Text] [Related]

  • 20. Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation.
    Reichenspurner H, Girgis RE, Robbins RC, Yun KL, Nitschke M, Berry GJ, Morris RE, Theodore J, Reitz BA.
    Ann Thorac Surg; 1996 Nov 15; 62(5):1467-72; discussion 1472-3. PubMed ID: 8893585
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.